Palonosetron
Palonosetron (Aloxi) is a long-acting anti-sickness injection given once before chemotherapy; a single dose covers both the first day and the delayed nausea that follows.
Overview
Palonosetron was approved by the FDA in July 2003 for prevention of acute and delayed nausea and vomiting with moderately emetogenic chemotherapy and acute nausea and vomiting with highly emetogenic chemotherapy, on randomised trials against ondansetron and dolasetron in which a single 0.25 mg dose was non-inferior in the acute phase and superior over five days; post-operative nausea (2008) and a paediatric indication from one month of age (2014) followed. The EU authorised Aloxi in 2005. It is the 5-HT3 partner in the Akynzeo fixed combination with netupitant and is preferred by MASCC/ESMO guidelines for moderately emetogenic regimens when an NK1 antagonist is not used. Headache and constipation are the main adverse effects, with less QT effect than first-generation agents.
Approvals
| Region | Year | Indication |
|---|---|---|
| US | 2003 | Acute and delayed nausea and vomiting with moderately emetogenic chemotherapy; acute with highly emetogenic chemotherapy (paediatric from 1 month added 2014) |
| EU | 2005 | Prevention of chemotherapy-induced nausea and vomiting (Aloxi) |
Trials
topRecruiting now (live from ClinicalTrials.gov)
Country and place are remembered in this browser only. A postcode is sent to OpenStreetMap's Nominatim service to find coordinates when you press the button; nothing else leaves your device.
Latest papers
topQuery for this drug: (TITLE:"Palonosetron" OR ABSTRACT:"Palonosetron" OR TITLE:"Aloxi" OR ABSTRACT:"Aloxi" OR TITLE:"Posfrea" OR ABSTRACT:"Posfrea") AND (cancer OR tumor OR tumour OR oncology OR carcinoma OR lymphoma OR leukemia OR leukaemia OR myeloma OR sarcoma OR melanoma OR glioma). Results are unfiltered search hits about Palonosetron, not a curated reading list.
Pages like this
not linked directly; found by shared links- ProductRolapitant
Shares Netupitant and palonosetron, Aprepitant (and fosaprepitant), Antiemetics for chemotherapy-induced nausea and vomiting and the tags nci-list, supportive.
- ProductDexamethasone
Shares Aprepitant (and fosaprepitant), Antiemetics for chemotherapy-induced nausea and vomiting and the tags nci-list, supportive.
- ProductAmifostine
Shares the tags nci-list, supportive.
- ProductDarbepoetin alfa
Shares the tags nci-list, supportive.
- ProductDefibrotide
Shares the tags nci-list, supportive.
- ProductDenosumab
Shares the tags nci-list, supportive.
- ProductDexrazoxane
Shares the tags nci-list, supportive.
- ProductEpoetin alfa
Shares the tags nci-list, supportive.